3,5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development?
Thyroid hormones, their metabolites, and synthetic analogues are potential anti-steatotic drug candidates considering that subclinical and manifest hypothyroidism is associated with hepatic lipid accumulation, non-alcoholic fatty liver disease, and its pandemic sequelae. Thyromimetically active comp...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2022-06-01
|
| シリーズ: | Metabolites |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/2218-1989/12/7/582 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
